Cargando…

Development of Stable Vibrio cholerae O1 Hikojima Type Vaccine Strains Co–Expressing the Inaba and Ogawa Lipopolysaccharide Antigens

We describe here the development of stable classical and El Tor V. cholerae O1 strains of the Hikojima serotype that co–express the Inaba and Ogawa antigens of O1 lipopolysaccharide (LPS). Mutation of the wbeT gene reduced LPS perosamine methylation and thereby gave only partial transformation into...

Descripción completa

Detalles Bibliográficos
Autores principales: Karlsson, Stefan L., Ax, Elisabeth, Nygren, Erik, Källgård, Susanne, Blomquist, Margareta, Ekman, Annelie, Benktander, John, Holmgren, Jan, Lebens, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232259/
https://www.ncbi.nlm.nih.gov/pubmed/25397871
http://dx.doi.org/10.1371/journal.pone.0108521
_version_ 1782344538096926720
author Karlsson, Stefan L.
Ax, Elisabeth
Nygren, Erik
Källgård, Susanne
Blomquist, Margareta
Ekman, Annelie
Benktander, John
Holmgren, Jan
Lebens, Michael
author_facet Karlsson, Stefan L.
Ax, Elisabeth
Nygren, Erik
Källgård, Susanne
Blomquist, Margareta
Ekman, Annelie
Benktander, John
Holmgren, Jan
Lebens, Michael
author_sort Karlsson, Stefan L.
collection PubMed
description We describe here the development of stable classical and El Tor V. cholerae O1 strains of the Hikojima serotype that co–express the Inaba and Ogawa antigens of O1 lipopolysaccharide (LPS). Mutation of the wbeT gene reduced LPS perosamine methylation and thereby gave only partial transformation into Ogawa LPS on the cell surface. The strains express approximately equal amounts of Inaba– and Ogawa–LPS antigens which are preserved after formalin–inactivation of the bacteria. Oral immunizations of both inbred and outbred mice with formalin–inactivated whole–cell vaccine preparations of these strains elicited strong intestinal IgA anti–LPS as well as serum vibriocidal antibody responses against both Inaba and Ogawa that were fully comparable to the responses induced by the licensed Dukoral vaccine. Passive protection studies in infant mice showed that immune sera raised against either of the novel Hikojima vaccine strains protected baby mice against infection with virulent strains of both serotypes. This study illustrates the power of using genetic manipulation to improve the properties of bacteria strains for use in killed whole–cell vaccines.
format Online
Article
Text
id pubmed-4232259
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-42322592014-11-26 Development of Stable Vibrio cholerae O1 Hikojima Type Vaccine Strains Co–Expressing the Inaba and Ogawa Lipopolysaccharide Antigens Karlsson, Stefan L. Ax, Elisabeth Nygren, Erik Källgård, Susanne Blomquist, Margareta Ekman, Annelie Benktander, John Holmgren, Jan Lebens, Michael PLoS One Research Article We describe here the development of stable classical and El Tor V. cholerae O1 strains of the Hikojima serotype that co–express the Inaba and Ogawa antigens of O1 lipopolysaccharide (LPS). Mutation of the wbeT gene reduced LPS perosamine methylation and thereby gave only partial transformation into Ogawa LPS on the cell surface. The strains express approximately equal amounts of Inaba– and Ogawa–LPS antigens which are preserved after formalin–inactivation of the bacteria. Oral immunizations of both inbred and outbred mice with formalin–inactivated whole–cell vaccine preparations of these strains elicited strong intestinal IgA anti–LPS as well as serum vibriocidal antibody responses against both Inaba and Ogawa that were fully comparable to the responses induced by the licensed Dukoral vaccine. Passive protection studies in infant mice showed that immune sera raised against either of the novel Hikojima vaccine strains protected baby mice against infection with virulent strains of both serotypes. This study illustrates the power of using genetic manipulation to improve the properties of bacteria strains for use in killed whole–cell vaccines. Public Library of Science 2014-11-14 /pmc/articles/PMC4232259/ /pubmed/25397871 http://dx.doi.org/10.1371/journal.pone.0108521 Text en © 2014 Karlsson et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Karlsson, Stefan L.
Ax, Elisabeth
Nygren, Erik
Källgård, Susanne
Blomquist, Margareta
Ekman, Annelie
Benktander, John
Holmgren, Jan
Lebens, Michael
Development of Stable Vibrio cholerae O1 Hikojima Type Vaccine Strains Co–Expressing the Inaba and Ogawa Lipopolysaccharide Antigens
title Development of Stable Vibrio cholerae O1 Hikojima Type Vaccine Strains Co–Expressing the Inaba and Ogawa Lipopolysaccharide Antigens
title_full Development of Stable Vibrio cholerae O1 Hikojima Type Vaccine Strains Co–Expressing the Inaba and Ogawa Lipopolysaccharide Antigens
title_fullStr Development of Stable Vibrio cholerae O1 Hikojima Type Vaccine Strains Co–Expressing the Inaba and Ogawa Lipopolysaccharide Antigens
title_full_unstemmed Development of Stable Vibrio cholerae O1 Hikojima Type Vaccine Strains Co–Expressing the Inaba and Ogawa Lipopolysaccharide Antigens
title_short Development of Stable Vibrio cholerae O1 Hikojima Type Vaccine Strains Co–Expressing the Inaba and Ogawa Lipopolysaccharide Antigens
title_sort development of stable vibrio cholerae o1 hikojima type vaccine strains co–expressing the inaba and ogawa lipopolysaccharide antigens
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232259/
https://www.ncbi.nlm.nih.gov/pubmed/25397871
http://dx.doi.org/10.1371/journal.pone.0108521
work_keys_str_mv AT karlssonstefanl developmentofstablevibriocholeraeo1hikojimatypevaccinestrainscoexpressingtheinabaandogawalipopolysaccharideantigens
AT axelisabeth developmentofstablevibriocholeraeo1hikojimatypevaccinestrainscoexpressingtheinabaandogawalipopolysaccharideantigens
AT nygrenerik developmentofstablevibriocholeraeo1hikojimatypevaccinestrainscoexpressingtheinabaandogawalipopolysaccharideantigens
AT kallgardsusanne developmentofstablevibriocholeraeo1hikojimatypevaccinestrainscoexpressingtheinabaandogawalipopolysaccharideantigens
AT blomquistmargareta developmentofstablevibriocholeraeo1hikojimatypevaccinestrainscoexpressingtheinabaandogawalipopolysaccharideantigens
AT ekmanannelie developmentofstablevibriocholeraeo1hikojimatypevaccinestrainscoexpressingtheinabaandogawalipopolysaccharideantigens
AT benktanderjohn developmentofstablevibriocholeraeo1hikojimatypevaccinestrainscoexpressingtheinabaandogawalipopolysaccharideantigens
AT holmgrenjan developmentofstablevibriocholeraeo1hikojimatypevaccinestrainscoexpressingtheinabaandogawalipopolysaccharideantigens
AT lebensmichael developmentofstablevibriocholeraeo1hikojimatypevaccinestrainscoexpressingtheinabaandogawalipopolysaccharideantigens